Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ECT plus nortriptyline versus ECT plus placebo for major depression
NL-OMON20033Active, not recruiting
- Sponsor
- Erasmus MC Rotterdam
- Start
- Mar 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial in major depressive disorder (MDD) comparing ECT + nortriptyline with ECT + placebo (2 arms). Primary endpoints: Mean change in HAM-D score, Proportion of responders and 1 more. Started Mar 2010; status: active, not recruiting.
02
Drugs
nortriptyline
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on NL-OMON20033.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON20033.